title: [Results of limb-saving surgery and prognostic factors in patients  with osteosarcoma].
abstract: Ninety six patients with high-grade osteosarcoma of the extremities were treated between 1986 and 1997 in the authors institution. They were divided into three groups: in group I, all of 75 patients with non-metastatic OS received intensive chemotherapy and underwent surgery. In group II, 9 patients already had metastases at the time of referral. In group III, 12 patients received chemotherapy in delayed or suboptimal form. In group I, local recurrences occurred in 7 per cent (3 patients), metastases in 20 per cent of the patients with limb-saving, whereas these numbers were 3 per cent and 38 per cent in the amputation group. The 5-year disease free survival (DFS) was 72% v 69% in the limb-saving and amputation group, respectively. In groups II and III, 5-year DFS was extremely poor, 10 and 20% only. With univariate analysis, factors having a positive influence on the survival were: tumor volume < 60 cm3, wide or radical surgical margin, distal location of osteosarcoma, cartilagineous ground substance less than 20% and response to chemotherapy. The last 4 variables maintained their significance in the multivariate Cox model as well. Age > 30 showed indirect negative influence on the final outcome (enhanced intolerability to the drugs and less co-operability of the patients etc.). This data confirm the competence of the limb-saving surgery at certain indications beside the amputation.
authors.affiliation: Ortopédiai Klinika, Semmelweis Egyetem, Budapest.
authors.forename: M
authors.initials: M
authors.lastname: Szendrói
authors.forename: I
authors.initials: I
authors.lastname: Antal
authors.forename: R
authors.initials: R
authors.lastname: Koós
authors.forename: G
authors.initials: G
authors.lastname: Kovács
authors.forename: Z
authors.initials: Z
authors.lastname: Pápai
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000671:Amputation, Surgical; D000704:Analysis of Variance; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D005121:Extremities / Q000601:surgery*; D005260:Female; D006801:Humans; D008297:Male; D012516:Osteosarcoma / Q000188:drug therapy / Q000601:surgery*; D011379:Prognosis; D016016:Proportional Hazards Models; D012307:Risk Factors; D013514:Surgical Procedures, Operative / Q000379:methods; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents